Nanoprecise Sci Corp | $38,000,000 | (Mar 28, 2025)
Mendel | $35,000,000 | (Mar 28, 2025)
Galatea Bio Inc. | $25,000,000 | (Mar 28, 2025)
Certified by Founder
Lodge
ADARx Pharmaceuticals Inc.
start up
United States
- San Diego, CA
- 10/08/2023
- Series C
- $200,000,000
ADARx Pharmaceuticals, Inc., located in San Diego, is a clinical stage biotechnology company committed to turning cutting-edge science into life-saving therapeutics. ADARx has developed proprietary RNA targeting platforms and oligonucleotide delivery technologies for inhibition, degradation, and editing disease-causing mRNA. ADARx has a growing pipeline of RNA targeting therapeutics for treating diseases across a range of therapeutic areas including genetic, cardiometabolic, complement-mediated diseases and central nervous system diseases. We are well-financed by a syndicate of renowned VC firms.
ADARx currently has multiple active programs in development. Our lead candidate is at the clinical stage.
- Industry Biotechnology Research
- Website https://www.adarx.com/
- LinkedIn https://www.linkedin.com/company/adarx-pharmaceuticals-inc/
MemryX Inc. | $44,000,000 | (Mar 28, 2025)
Mila Beauté | $2,160,000 | (Mar 28, 2025)
Lucky Beverage Co. | $14,200,000 | (Mar 28, 2025)
Taxo (YC S24) | $5,000,000 | (Mar 28, 2025)
BuildVision | $10,000,000 | (Mar 28, 2025)
Yutori | $15,000,000 | (Mar 28, 2025)
Nexthop AI | $110,000,000 | (Mar 27, 2025)
Topanga.io | $8,000,000 | (Mar 27, 2025)
Silna | $27,000,000 | (Mar 27, 2025)